VIRX: viracta.com Cash Calculated per Single Share

Symbol and logo of brand Viracta Therapeutics, Inc. (VIRX)

Viracta Therapeutics (VIRX) is valued by the scientific community for its highly specialized developments in the fight against EBV-oncology. The cash per share trend demonstrates financial stability, where 0.00 represents the current level of the metric. The company's advantage is its unique "Kick and Kill" method for eliminating rare lymphomas. Operations are strictly regulated by FDA standards for biomaterial disposal, ensuring compliance with medical standards.

viracta.com (VIRX): Cash per Single Share from 07/04/2022 to 02/16/2025

Comprehensive metric breakdowns and analytics for viracta.com (VIRX)

- stock value and consensus price forecast:
- cash and cash flow data:
Summary company analysis:VIRX (Viracta Therapeutics Inc.)
Finished products of Viracta Therapeutics

Analyzing the net cash position per share allows for an assessment of the financial stability of Viracta Therapeutics (VIRX) within the onco-pharmaceutical sector. This metric determines the volume of liquid assets attributable to a single common share by subtracting liabilities from total capital. The trend of this indicator reflects resource management efficiency and the risk of shareholder dilution. The automation of biomarker laboratory analysis optimizes expenses, thereby slowing the cash burn rate. A stable level of this indicator confirms the company's ability to fund strategic developments without the urgent need to raise debt capital.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|AONC: Cash per Share|Cash on Hand per Share BeOne Medicines (BGNE)|Cash Funds per Share Checkpoint Therapeutics, Inc.|Cash per Single Share Elevation Oncology (ELEV)|Cash Funds per Share iCAD Corp (ICAD)|Cash per Single Share Ikena IKNA|Cash per Share NTBL (notablelabs.com)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com